Skip to content

KF2024#1 trial: Esketamine interaction study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-516892-34-00
Enrollment
12
Registered
2024-11-01
Start date
2024-12-03
Completion date
2025-04-29
Last updated
2024-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

None listed

Sponsors

HUS-Yhtymae
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Finland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026